Innovations in Pain Management: A Technology Blueprint to Counter Opiod Addiction

1.1 Research Scope

1.2 Research Methodology

1.3 Miniaturization, Cybersecurity, and Wearables are Technology Trends Driving Industry Growth

1.4 Resistance toward Intake of Opioids Drive Growth of Device-based Therapies

1.5 Progressive Shift toward Very High Margin Pain Management Therapies

2.1 50% of Device-based Pain Management Therapies Market Comprises of Neuromodulation Therapies

2.2 Patent Expiry of Blockbuster Drugs is Driving the Sales of Device-based Therapies

2.3 Device-based Therapies Work at a Organ Level, Enhancing Clinical Effectiveness

2.4 Strong Regulatory Push toward Use of Pain Control Devices against Use of Opioids

2.5 North America is Most Favourable for Wide-Scale Launch and Commercialization of Pain Management Devices

3.1 Strong Competitive Push from Combination Products and Device Therapies against Drug Therapies for Pain Control

3.2 Combination Therapies are Replacing Drug Therapies for Managing various Pain Disorders

3.3 eCommerce Plays a Critical Role in Driving Adoption of Pain Management Devices

3.4 The US and Japan are Generating Innovative Intellectual Property Assets around Pain Management Therapies

3.5 Development of Hybrid Therapy Systems are Increasing the Pace of Mergers & Acquisitions within the Industry

3.6 Co-creation Plays a Critical Role in Developing Clinically Safe & Effective Pain Management Therapies

4.1 Four Major End-user Segments Define Majority of Market for Pain Management Therapies

4.2 A Critical Demand Exists for Reimbursement of Pain Management Therapies in Regions outside United States

5.1 Value Adding Stakeholders are Critical to Innovation for the Global Pain Management Industry

5.2 University Research Grants in Emerging Economies are Not Adequately Supported for Commercialization of New Therapies

5.3 CROs Play a Critical Role in Complying with Regulatory Requirements of New Markets

5.4 Hospitals Still Serve to be Major Brand Advocates for Pain Management Therapies

5.5 MedTech and Pharma Companies Need to Focus on Creating Innovation Networks

6.1 Value of Care is a Ratio of Health Outcomes Delivered to the Ease of Access to the Therapy

6.2 Invasive Options – Electrical Stimulation & Intrathecal Pumps are Delivering High Value of Care to Patients

7.1 Bundled Care and Low Claim Complexity are Critical to Adoption among Mass Market Segments

7.2 Setting the Right Design Elements Early During Product Development Enhances Speed of Commercialization

7.3 Good Market Potential for Development of Therapies that can Detect Pain and Also Deliver Appropriate Therapy

8.1 North America, Australia, and China Dominate the Global Patent Landscape with a High Intensity of Patents

8.2 Development of Implantable Neuromodulation System using Current Distribution Circuitry

8.3 New Intellectual Properties Developed Around Nasal Stimulation Methods

8.4 Development of Conductive Pad for Effective Pain Relieving

8.5 Key Contacts

8.5 Key Contacts (continued)

Legal Disclaimer